UTRS (Minerva Surgical) Revenue: $51.69 Mil (TTM As of Sep. 2023)


What is Minerva Surgical Revenue?

Minerva Surgical UTRS -99.00% Revenue is $51.69 Mil as of Sep. 2023.

Minerva Surgical's revenue for the three months ended in Sep. 2023 was $11.97 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $51.69 Mil. Minerva Surgical's Revenue per Share for the three months ended in Sep. 2023 was $1.35. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $14.84.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Minerva Surgical  (OTCPK:UTRS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Minerva Surgical Revenue Related Terms


Minerva Surgical Revenue Historical Data

* Premium members only.

The historical data trend for Minerva Surgical's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Surgical Revenue Chart

Minerva Surgical Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Revenue
26.01 37.77 52.10 50.29

Minerva Surgical Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.59 13.80 12.53 13.39 11.97

UTRS vs PAVM, ELUT, COCH: Revenue Comparison

For the Medical Devices subindustry, Minerva Surgical's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minerva Surgical Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Minerva Surgical's Revenue distribution charts can be found below:

* The bar in red indicates where Minerva Surgical's Revenue falls into.



Minerva Surgical Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $51.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $51.69 Mil mean?
Minerva Surgical (UTRS) has a Revenue of $51.69 Mil as of Sep. 2023. Revenue is the total amount a company generates as sales through its operations. View historical data on Minerva Surgical and its competitors.
Is Minerva Surgical's Revenue too high?
Minerva Surgical's current Revenue is $51.69 Mil.
How does Minerva Surgical's Revenue compare to PAVM and ELUT?
Minerva Surgical's Revenue of $51.69 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Minerva Surgical and its competitors. Minerva Surgical's current Revenue is $51.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Surgical stock overvalued right now?
Minerva Surgical (UTRS) has a current Revenue of $51.69 Mil. The current Revenue is $51.69 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Minerva Surgical (UTRS), the current Revenue is $51.69 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Surgical Business Description

Address 4255 Burton Drive, Santa Clara, CA, USA, 95054
Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.